Involvement of the TGF-β1 Derived from Megakaryocyte in the PEG-rHuMGDF-Induced Myelofibrosis and Bone Formation
スポンサーリンク
概要
- 論文の詳細を見る
Bone marrow fibrosis and new bone formation were induced by Pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) injection in the rat. We investigated time course changes of megakaryocyte counts, circulating platelet counts, transforming growth factor-β1 (TGF-β1) levels in the bone marrow and those in platelet-poor plasma (PPP) when rats were injected with PEG-rHuMGDF at a dose of 0.1 mg/kg. Additionally, ultrastructural analysis of the circulating platelet and the bone marrow was performed by electron microscope. PEG-rHuMGDF injection daily for 5 days caused a megakaryocyte hyperplasia on days 5-7[after the commencement of the treatment], myelofibrosis on days 7-10, and new bone formation on days 8-15. TGF-β1 levels in the extracellular fluid of the marrow, megakaryocyte numbers, TGF-β1 levels in the PPP, and circulating platelet counts increased by PEG-rHuMGDF injection, and reached to the maximum level on days 7, 7, 8, and 10, respectively. Ultrastructural analysis showed that circulating platelets had no prominent morphological changes in the PEG-rHuMGDF-treated rats on day 8, compared with vehicle-treated rats. Additionally, there were many platelets or fragments of megakaryocyte around mesenchymal cells, and those fragments deposited in the newly formed bone on day 10. These data suggested that myelofibrosis and new bone formation were induced by the increase of TGF-β1 levels derived from bone marrow megakaryocytes.
- 日本毒性病理学会の論文
- 2002-03-25
著者
-
Doi Kunio
Department of Veterinary Pathology, Faculty of Agriculture, The University of Tokyo
-
Doi Kunio
Department Of Applied Chemistry Nagoya Institute Of Technology
-
Kawahara Jun-ichi
Pharmaceutical Development Lab. Kirin Brewery Co. Ltd.
-
Kawahara Jun-ichi
Pharmaceutical Development Laboratories Kirin Brewery Co. Ltd.
-
Iijima Rieko
Pharmaceutical Development Laboratories Kirin Brewery Co. Ltd.
-
HARADA Katsuhiko
Pharmaceutical Development Laboratory, Kirin Brewery Co., Ltd.
-
IDE Youichi
Pharmaceutical Development Laboratories, Kirin Brewery Co., Ltd.
-
YAMANAKA Eri
Pharmaceutical Development Laboratories, Kirin Brewery Co., Ltd.
-
NAMIKI Yasuko
Pharmaceutical Development Laboratories, Kirin Brewery Co., Ltd.
-
ISHI Hiromi
Pharmaceutical Development Laboratories, Kirin Brewery Co., Ltd.
-
Ide Youichi
Pharmaceutical Development Laboratories Development Department Pharmaceutical Division Kirin Brewery
-
Ide Youichi
Pharmaceutical Development Laboratories Kirin Brewery Co. Ltd.
-
Ishi Hiromi
Pharmaceutical Development Laboratories Kirin Brewery Co. Ltd.
-
Yamanaka Eri
Pharmaceutical Development Laboratories Kirin Brewery Co. Ltd.
-
Namiki Yasuko
Pharmaceutical Development Laboratories Kirin Brewery Co. Ltd.
-
Harada Katsuhiko
Pharmaceutical Development Laboratories Kirin Brewery Co. Ltd.
関連論文
- Differences in bone responses to recombinant human granulocyte colony-stimulating factor between mice and rats
- Involvement of Sex, Strain and Age Factors in High Fat Diet-Induced Obesity in C57BL/6J and BALB/cA Mice
- Recovery from pregnancy-induced down-regulation of cytochrome P450 isozymes (CYPs) protein levels in postpartum rat liver(Proceedings of the 32nd Annual Meeting)
- Age-Dependent Susceptibility to MPTP Neurotoxicity in C57BL Mice : A Tyrosine Hydroxylase-Immunohistochemical Evaluation
- The Susceptibility of Pregnant Mice to Encephalomyocarditis (EMC) Virus Infection on Different Days of Gestation
- 1-β-D-Arabinofuranosylcytosine (Ara-C)-induced Apoptosis in the Rat Fetal Tissues and Placenta
- Gene Expression Profiles in the Liver, Placenta and Fetal Liver in Pregnant Rats Treated with T-2 Toxin (TOXICOGENOMICS AND TOXICOPROTEOMICS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- DNA Damages and Changes in Proliferating Activity in the Dorsal Epidermis of UVB-Irradiated WBN/ILA-Ht Rats
- T-2 Toxin-Induced Morphological Changes in Pregnant Rats
- Effects of Exogenous Growth Hormone (GH)-Treatment on Carbon Tetrachloride (CCl_4)-Induced Acute Liver Injury in GH-Deficient Mini Rats